|
关于:
|
Cost-Utility Examination involving Fixed-Dose Combination of Indacaterol Acetate Glycopyrronium Bromide and Mometasone Furoate as being a Servicing Remedy throughout Grown-up People with Bronchial asthma Certainly not Sufficiently Manipulated having a Servicing Blend of a new Long-Acting Beta-Agonist plus a Higher Dosage of the Breathed in Corticosteroid Who Experienced One or even more Asthma Exacerbations in the earlier Yr.
|
